Veracyte | VCYT - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agenus USD -271.11M 3.03M 2025-12
Agilent USD 6.91B 167M 2025-12
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Exact Sciences USD 2.4B 100.37M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Illumina USD 2.72B 342M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Laboratory Of America USD 8.62B 93.2M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Siemens EUR 65.48B 3.24B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Veracyte USD 1.26B 36.61M 2025-09
Waters USD 2.56B 230.55M 2025-12